Cash on Hand for AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's latest reported cash and short-term investments is $5.26B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
ABBV
Currently viewingCash on HandSwitch metric
Latest period
$5.26B
YoY change
-5.4%
5Y CAGR
-9.1%
Peak year (2019)
$39.92B
Latest annual
$5.26B
Cash on Hand history chart for AbbVie (ABBV) from 2010 to 2025
Cash on Hand history table for AbbVie (ABBV) from 2010 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $5.26B | -5.4% | ||
| 2024 | $5.55B | -56.7% | ||
| 2023 | $12.82B | +38.9% | ||
| 2022 | $9.23B | -6.1% | ||
| 2021 | $9.83B | +15.9% | ||
| 2020 | $8.48B | -78.8% | ||
| 2019 | $39.92B | +395.3% | ||
| 2018 | $8.06B | -17.7% | ||
| 2017 | $9.79B | +52.4% | ||
| 2016 | $6.42B | -23.6% | ||
| 2015 | $8.41B | +0.4% | ||
| 2014 | $8.37B | -15.4% | ||
| 2013 | $9.89B | +24.1% | ||
| 2012 | $7.98B | +1121.4% | ||
| 2011 | $653.00M | +5960.3% | ||
| 2010 | $10.78M | — |
Cash on Hand values are taken from AbbVie's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, AbbVie (ABBV) reported cash and short-term investments of $5.26B – declined 5.4% year-over-year.
Looking at the 2020–2025 (5 years) stretch, AbbVie cash and short-term investments compounded at -9.1% per year, with a net decline across the window.
AbbVie cash and short-term investments plunged from $39.92B in 2019 to $5.26B in 2025, a 86.8% drawdown.
Across the available history, cash and short-term investments reached its high of $39.92B in 2019 and its low of $10.78M in 2010.
Among 8 Healthcare peers, AbbVie (ABBV) ranks 9th; the peer median for cash and short-term investments is $12.34B.
AbbVie Cash on Hand by Year
AbbVie Cash on Hand 2025: $5.26B
AbbVie cash and short-term investments in 2025 was $5.26B, declined 5.4% below 2024.
AbbVie Cash on Hand 2024: $5.55B
AbbVie cash and short-term investments in 2024 was $5.55B, plunged 56.7% below 2023.
AbbVie Cash on Hand 2023: $12.82B
AbbVie cash and short-term investments in 2023 was $12.82B, surged 38.9% from 2022.
AbbVie Cash on Hand 2022: $9.23B
AbbVie cash and short-term investments in 2022 was $9.23B, declined 6.1% below 2021.
AbbVie Cash on Hand 2021: $9.83B
AbbVie cash and short-term investments in 2021 was $9.83B.
See more financial history for AbbVie (ABBV).
Sector peers — Cash on Hand
Companies in the same sector as AbbVie, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $10.11B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
Frequently asked questions
What is AbbVie's cash and short-term investments?
- Latest reported cash and short-term investments for AbbVie (ABBV) is $5.26B (period ending December 31, 2025).
How has AbbVie cash and short-term investments changed year-over-year?
- AbbVie (ABBV) cash and short-term investments changed -5.4% year-over-year on the latest annual filing.
What is the long-term growth rate of AbbVie cash and short-term investments?
- AbbVie (ABBV) cash and short-term investments compound annual growth rate is -9.1% over the most recent 5 years available.
When did AbbVie cash and short-term investments hit its highest annual value?
- AbbVie cash and short-term investments reached its highest annual value of $39.92B in 2019.
What was AbbVie cash and short-term investments in 2024?
- AbbVie (ABBV) cash and short-term investments in 2024 was $5.55B.
What was AbbVie cash and short-term investments in 2025?
- AbbVie (ABBV) cash and short-term investments in 2025 was $5.26B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABBV Overview
Company profile, financial tools, and key metrics
ABBV Revenue Counter
Earns $1,939 every second. See per minute, hour, and day.
ABBV Earnings Counter
Earns $134.01 per second net profit. See per minute, hour, and day.
ABBV Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
ABBV What If Invested
What if you had invested $1,000? See historical returns from any date.
ABBV How It Makes Money
Discover visual breakdown of $61.16B in revenue — where it comes from and where it goes.
ABBV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABBV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABBV Daily Price Character
Steady · 53.5% historical win rate (green days). Streaks & record days.
ABBV Buybacks
0.24% TTM buyback yield. Shareholder yield & SBC comparison.
ABBV Dividend Profile
Yield: 3.31%. Safety: 6/8. See full history.
ABBV Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABBV Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.